Am J Clin Pathol

1. MARLETTA S, Eccher A, Martelli FM, Santonicco N, et al
   Artificial intelligence-based algorithms for the diagnosis of prostate cancer: A systematic review.
   Am J Clin Pathol. 2024 Feb 21:aqad182. doi: 10.1093.
   

   >> Share

   
   
2. BERGHOLTZ SE, Kurnot SR, Elahi E, DeJonckheere M, et al
   A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer.
   Am J Clin Pathol. 2024 Feb 22:aqae008. doi: 10.1093.
   

   >> Share

   
   

   
   BJU Int

3. HONORE A, Moen CA, Juliebo-Jones P, Reisaeter LAR, et al
   Transitioning from transrectal to transperineal prostate biopsy using a freehand cognitive approach.
   BJU Int. 2024;133:324-331.
   

   >> Share

   
   

   
   BMC Urol

4. GOUDARZI Z, Lotfi F, Najafpour Z, Hafezi A, et al
   Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran.
   BMC Urol. 2024;24:45.
   

   >> Share

   
   
5. FENG X, Chen X, Peng P, Zhou H, et al
   Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis.
   BMC Urol. 2024;24:40.
   

   >> Share

   
   

   
   Br J Cancer

6. LIU Q, Zhang Y, Vaselkiv JB, Mucci LA, et al
   A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study.
   Br J Cancer. 2024 Feb 22. doi: 10.1038/s41416-024-02593.
   

   >> Share

   
   

   
   Cancer Imaging

7. ROSAR F, Burgard C, Larsen E, Khreish F, et al
   [(89)Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [(68)Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis.
   Cancer Imaging. 2024;24:27.
   

   >> Share

   
   

   
   Cancer Lett

8. CHEN H, Dong K, Ding J, Xia J, et al
   CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression.
   Cancer Lett. 2024 Feb 14:216725. doi: 10.1016/j.canlet.2024.216725.
   

   >> Share

   
   

   
   Discov Oncol

9. ZONG S, Gao J
   Identifying the tumor immune microenvironment-associated prognostic genes for prostate cancer.
   Discov Oncol. 2024;15:42.
   

   >> Share

   
   

   
   Endocrinology

10. BAE SY, Kamalanathan K, Galeano-Garces C, Konety BR, et al
    Dissemination of circulating tumor cells in breast and prostate cancer: Implications for early detection.
    Endocrinology. 2024 Feb 15:bqae022. doi: 10.1210.
    

    >> Share

    
    

    
    Eur J Radiol

11. GIGANTI F, Asbach P
    The backbone of prostate MRI: Technical acquisition and image quality.
    Eur J Radiol. 2024;172:111320.
    

    >> Share

    
    

    
    Eur Urol

12. POPE B, Park G, Lau E, Belic J, et al
    Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.
    Eur Urol. 2024 Feb 19:S0302-2838(24)00003-4. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    
13. FENG D, Wang J, Wu R, Li D, et al
    Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer.
    Eur Urol. 2024 Feb 17:S0302-2838(24)00069-1. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    
14. DE VOS II, Remmers S, Roobol MJ
    Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renee Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinui
    Eur Urol. 2024 Feb 17:S0302-2838(24)00057-5. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    

    
    Hum Pathol

15. MAHLOW J, Barry M, Albertson DJ, Jo YJ, et al
    Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
    Hum Pathol. 2024;144:28-33.
    

    >> Share

    
    

    
    J Natl Cancer Inst

16. BASU A, Rais-Bahrami S
    Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?
    J Natl Cancer Inst. 2024 Feb 16:djae025. doi: 10.1093.
    

    >> Share

    
    

    
    Prostate

17. YE PC, Leu WJ, Yeh TY, Hsu YT, et al
    A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
    Prostate. 2024 Feb 20. doi: 10.1002/pros.24678.
    

    >> Share

    
    
18. WHITE JA, Kaninjing ET, Adeniji KA, Jibrin P, et al
    Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    Prostate. 2024 Jan 8. doi: 10.1002/pros.24662.
    

    >> Share

    
    

    
    Radiologia (Engl Ed)

19. ALONSO-GONZALEZ R, Abadal Villayandre JM, Galvez Gonzalez E, Alvarez Perez MJ, et al
    Irreversible electroporation: Beyond the limits of tumor ablation.
    Radiologia (Engl Ed). 2024;66:47-56.
    

    >> Share

    
    

    
    Urology

20. PASSARELLI R, Srivastava A
    Editorial Comment: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 20:S0090-4295(24)00091-8. doi: 10.1016/j.urology.2024.
    

    >> Share

    
    
21. HUNG M, Ross A, Li EV, Pavlovich CP, et al
    Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 20:S0090-4295(24)00093-1. doi: 10.1016/j.urology.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share